These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 9774108

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Identification of a critical ligand binding determinant of the human erythropoietin receptor. Evidence for common ligand binding motifs in the cytokine receptor family.
    Middleton SA, Johnson DL, Jin R, McMahon FJ, Collins A, Tullai J, Gruninger RH, Jolliffe LK, Mulcahy LS.
    J Biol Chem; 1996 Jun 14; 271(24):14045-54. PubMed ID: 8662939
    [Abstract] [Full Text] [Related]

  • 24. Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors.
    Fichelson S, Chrétien S, Rokicka-Piotrowicz M, Bouhanik S, Gisselbrecht S, Mayeux P, Lacombe C.
    Biochem Biophys Res Commun; 1999 Mar 24; 256(3):685-91. PubMed ID: 10080960
    [Abstract] [Full Text] [Related]

  • 25. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
    Chen J, Jacobs-Helber SM, Barber DL, Sawyer ST.
    Exp Cell Res; 2004 Aug 01; 298(1):155-66. PubMed ID: 15242770
    [Abstract] [Full Text] [Related]

  • 26. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
    Feldman L, Wang Y, Rhim JS, Bhattacharya N, Loda M, Sytkowski AJ.
    Prostate; 2006 Feb 01; 66(2):135-45. PubMed ID: 16161153
    [Abstract] [Full Text] [Related]

  • 27. Erythropoietin Receptor Structural Domains.
    Li Q, Kang C.
    Vitam Horm; 2017 Feb 01; 105():1-17. PubMed ID: 28629512
    [Abstract] [Full Text] [Related]

  • 28. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP, Rajashankar KR, Lackmann M, Cowan CA, Henkemeyer M, Nikolov DB.
    Nature; 2017 Feb 01; 414(6866):933-8. PubMed ID: 11780069
    [Abstract] [Full Text] [Related]

  • 29. Increased potency of an erythropoietin peptide mimetic through covalent dimerization.
    Wrighton NC, Balasubramanian P, Barbone FP, Kashyap AK, Farrell FX, Jolliffe LK, Barrett RW, Dower WJ.
    Nat Biotechnol; 1997 Nov 01; 15(12):1261-5. PubMed ID: 9359108
    [Abstract] [Full Text] [Related]

  • 30. BMP-3 and BMP-6 structures illuminate the nature of binding specificity with receptors.
    Allendorph GP, Isaacs MJ, Kawakami Y, Izpisua Belmonte JC, Choe S.
    Biochemistry; 2007 Oct 30; 46(43):12238-47. PubMed ID: 17924656
    [Abstract] [Full Text] [Related]

  • 31. Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide.
    Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, Jin R, Livnah O, Tullai J, Farrell FX, Goldsmith MA, Wilson IA, Jolliffe LK.
    J Biol Chem; 1999 May 14; 274(20):14163-9. PubMed ID: 10318834
    [Abstract] [Full Text] [Related]

  • 32. A potent erythropoietin-mimicking human antibody interacts through a novel binding site.
    Liu Z, Stoll VS, Devries PJ, Jakob CG, Xie N, Simmer RL, Lacy SE, Egan DA, Harlan JE, Lesniewski RR, Reilly EB.
    Blood; 2007 Oct 01; 110(7):2408-13. PubMed ID: 17620453
    [Abstract] [Full Text] [Related]

  • 33. Ligand binding properties of the human erythropoietin receptor extracellular domain expressed in Escherichia coli.
    Harris KW, Mitchell RA, Winkelmann JC.
    J Biol Chem; 1992 Jul 25; 267(21):15205-9. PubMed ID: 1321832
    [Abstract] [Full Text] [Related]

  • 34. The role of asymmetric binding in ligand-receptor systems with 1:2 interaction ratio.
    Míguez DG.
    Biophys Chem; 2010 May 25; 148(1-3):74-81. PubMed ID: 20332059
    [Abstract] [Full Text] [Related]

  • 35. Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin.
    Zhan H, Liu B, Reid SW, Aoki KH, Li C, Syed RS, Karkaria C, Koe G, Sitney K, Hayenga K, Mistry F, Savel L, Dreyer M, Katz BA, Schreurs J, Matthews DJ, Cheetham JC, Egrie J, Giebel LB, Stroud RM.
    Protein Eng; 1999 Jun 25; 12(6):505-13. PubMed ID: 10388848
    [Abstract] [Full Text] [Related]

  • 36. Changes in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptor.
    Narhi LO, Aoki KH, Philo JS, Arakawa T.
    J Protein Chem; 1997 Apr 25; 16(3):213-25. PubMed ID: 9155092
    [Abstract] [Full Text] [Related]

  • 37. Evaluating energetics of erythropoietin ligand binding to homodimerized receptor extracellular domains.
    Hensley P, Doyle ML, Myszka DG, Woody RW, Brigham-Burke MR, Erickson-Miller CL, Griffin CA, Jones CS, McNulty DE, O'Brien SP, Amegadzie BY, MacKenzie L, Ryan MD, Young PR.
    Methods Enzymol; 2000 Apr 25; 323():177-207. PubMed ID: 10944753
    [No Abstract] [Full Text] [Related]

  • 38. Tuning cytokine receptor signaling by re-orienting dimer geometry with surrogate ligands.
    Moraga I, Wernig G, Wilmes S, Gryshkova V, Richter CP, Hong WJ, Sinha R, Guo F, Fabionar H, Wehrman TS, Krutzik P, Demharter S, Plo I, Weissman IL, Minary P, Majeti R, Constantinescu SN, Piehler J, Garcia KC.
    Cell; 2015 Mar 12; 160(6):1196-208. PubMed ID: 25728669
    [Abstract] [Full Text] [Related]

  • 39. The molecular physiology of erythropoietin and the erythropoietin receptor.
    Zhu Y, D'Andrea AD.
    Curr Opin Hematol; 1994 Mar 12; 1(2):113-8. PubMed ID: 9371269
    [Abstract] [Full Text] [Related]

  • 40. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A.
    Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA.
    Science; 1996 Jul 26; 273(5274):464-71. PubMed ID: 8662530
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.